Evaluation of Salivary Gland Dysfunction
NCT00001196 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1740
Last updated 2017-07-02
Summary
This study will evaluate patients with complaints of dry mouth to determine the cause and severity of their salivary gland dysfunction and their possible eligibility for other NIDCR protocols. Salivary gland secretions have antibacterial, lubricatory, remineralizing, digestive, buffering and cleansing properties. Impaired function of these glands can cause an increase in tooth decay; a variety of oral hard and soft tissue changes, with painful, burning, or ulcerated oral mucosal; problems chewing, swallowing, and speaking; and diminished taste and smell.
Patients with dry mouth complaints suggestive of salivary gland dysfunction may be eligible for this study. In addition, patients with recent onset of arthritis may enroll. Patients with arthritis are at risk for developing a disorder called Sjogren's syndrome, in which the glands that produce saliva may be damaged.
Participants will have a complete medical and dental history. Saliva samples will be collected from the major salivary glands, which are located in the cheeks and under the jaw. Several blood samples will also be drawn for tests. Some patients will have a biopsy of the minor salivary glands, usually from the lower lip, to confirm or rule out the diagnosis of Sjogren's syndrome and determine the extent of changes in the salivary glands. The ability to taste and smell may also be evaluated, and patients may have an ultrasound examination of their swallowing function.
Conditions
- Sjogren's Syndrome
- Salivary Gland
Sponsors & Collaborators
-
National Institute of Dental and Craniofacial Research (NIDCR)
lead NIH
Principal Investigators
-
Ilias G Alevizos, D.M.D. · National Institute of Dental and Craniofacial Research (NIDCR)
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1984-03-23
- Completion
- 2015-09-29
Countries
- United States
Study Locations
More Related Trials
-
The Pathogenesis and Natural History of Sjogren's Disease
NCT01425892 ·Status: RECRUITING
-
The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers
NCT00001953 ·Status: COMPLETED
-
Salivary Proteins in Disease and Health
NCT00100204 ·Status: COMPLETED
-
Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
NCT02112019 ·Status: UNKNOWN ·Phase: NA
-
Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells
NCT00023491 ·Status: COMPLETED
-
Salivary Markers in Patients With Xerostomia
NCT03156569 ·Status: COMPLETED
-
Evaluation of the Role of the Autonomic Nervous System in Sj(SqrRoot)(Delta)Gren s Syndrome
NCT00565526 ·Status: COMPLETED
-
Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects
NCT01316770 ·Status: TERMINATED ·Phase: PHASE2
-
BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent
NCT02068846 ·Status: COMPLETED ·Phase: PHASE3
-
Functional Analysis of Salivary Glands and Correlation With Sialoscintigraphy in Sjogren's Syndrome
NCT06536075 ·Status: RECRUITING ·Phase: NA
-
CLINICAL EVALUATION OF THE EFFICACY OF AN INTRA ORAL SPRAY FOR PATIENTS WITH XEROSTOMIA
NCT04719091 ·Status: COMPLETED ·Phase: NA
-
Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease
NCT06805448 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Effect of Saliva Substitutes on Dental Hard Tissues in Situ
NCT01165970 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
NCT02641912 ·Status: COMPLETED ·Phase: NA
-
Evaluation and Treatment of Oral Soft Tissue Diseases
NCT00001601 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva
NCT01690052 ·Status: COMPLETED ·Phase: NA
-
The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome
NCT05680064 ·Status: COMPLETED ·Phase: NA
-
Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.
NCT05124925 ·Status: COMPLETED ·Phase: PHASE2
-
Dental and Periodontal Status of Patients With Sjögren's Syndrome.
NCT04848870 ·Status: RECRUITING
-
Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease
NCT04212572 ·Status: UNKNOWN
-
Gingival Wetness and Gingival Crevicular Fluid Volume in Patients With Dry Mouth
NCT00750828 ·Status: COMPLETED
-
Ultrasound Elastography of Salivary Glands
NCT02994797 ·Status: COMPLETED
-
An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness
NCT01369589 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
This Present Study Can be Used by Clinicians Who Treat Psychiatric Patients: Dentists Might Expect Xerogenic Side Effects of Specific Psychiatric Drugs Which Can Affect Dental Treatment, and the Results Can Help Psychiatrist to Choose the Less Xerogenic Psychiatric Medication
NCT06920472 ·Status: COMPLETED
-
Testing of a New Scale Measuring Medical Outcomes of Dysphagia (MOD) in Adult Patients With Swallowing Disorders
NCT01419886 ·Status: COMPLETED